申请人:NOVO NORDISK HEALTH CARE AG
公开号:US20170035890A1
公开(公告)日:2017-02-09
The present invention relates to Factor IX polypeptides conjugated to heparosan (HEP) polymers, methods for the manufacture thereof and uses of such conjugates. The resultant conjugates may be used—for example—in the treatment or prevention of bleeding disorders such as haemophilia B.